1. V617F “JAKs” up myeloproliferative signal
by Ayalew Tefferi
Blood
Volume 106(10):
November 15, 2005
©2005 by American Society of Hematology

2. Phenotypic diversity associated with the JAK2 V617F tyrosine kinase mutation might arise from a combination of the particular myeloid progenitor compartment that is affected and specific secondary mutations that occur during clonal evolution.
Phenotypic diversity associated with theJAK2V617F tyrosine kinase mutation might arise from a combination of the particular myeloid progenitor compartment that is affected and specific secondary mutations that occur during clonal evolution.
Ayalew Tefferi Blood 2005;106:
©2005 by American Society of Hematology